Board Meetings for KREBSBIO

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
KREBSBIOKrebs Biochemicals and Industries Limited21 May 2026Financial Results/Other business mattersTo consider and approve the financial results for the period ended March 31, 2026 and other business matters
KREBSBIOKrebs Biochemicals and Industries Limited21 May 2026Board Meeting IntimationKREBS BIOCHEMICALS AND INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 21-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Other business.
KREBSBIOKrebs Biochemicals and Industries Limited09 Feb 2026Financial Results/Other business mattersTo consider and approve the financial results for the period ended December 31, 2025 and other business matters
KREBSBIOKrebs Biochemicals and Industries Limited09 Feb 2026Board Meeting IntimationKREBS BIOCHEMICALS AND INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 09-Feb-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Other business.
KREBSBIOKrebs Biochemicals and Industries Limited04 Nov 2025Financial Results/Other business mattersTo consider and approve the financial results for the period ended September 30, 2025 and other business matters
KREBSBIOKrebs Biochemicals and Industries Limited04 Nov 2025Board Meeting IntimationKREBS BIOCHEMICALS AND INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2025 and Other business.
KREBSBIOKrebs Biochemicals and Industries Limited07 Aug 2025Board Meeting IntimationKREBS BIOCHEMICALS AND INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 07-Aug-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2025 and Other business.
KREBSBIOKrebs Biochemicals and Industries Limited07 Aug 2025Financial Results/Other business mattersTo consider and approve the financial results for the period ended Jun 30, 2025 and other business matters
KREBSBIOKrebs Biochemicals and Industries Limited20 May 2025Financial Results/Other business mattersTo consider and approve the financial results for the period ended March 31, 2025 and other business matters
KREBSBIOKrebs Biochemicals and Industries Limited20 May 2025Board Meeting IntimationKREBS BIOCHEMICALS AND INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 20-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Other business.
KREBSBIOKrebs Biochemicals and Industries Limited04 Feb 2025Board Meeting IntimationKREBS BIOCHEMICALS AND INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 04-Feb-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2024 and Other business.
KREBSBIOKrebs Biochemicals and Industries Limited04 Feb 2025Financial Results/Other business mattersTo consider and approve the financial results for the period ended December 31, 2024 and other business matters
KREBSBIOKrebs Biochemicals and Industries Limited11 Nov 2024Financial Results/Other business mattersTo consider and approve the financial results for the period ended September 30, 2024 and other business matters
KREBSBIOKrebs Biochemicals and Industries Limited11 Nov 2024Board Meeting IntimationKREBS BIOCHEMICALS AND INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 11-Nov-2024 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2024 and Other business.
KREBSBIOKrebs Biochemicals and Industries Limited07 Aug 2024Financial Results/Other business mattersThe Company has informed that the meeting of Board of Directors of the Company is schedule on 07/08/2024 inter alia to consider and approve Unaudited Financial Results for the quarter ended 30th June 2024.
Showing page 1 of 8 (117 total items)
Next